By continuing to browse the site, you are agreeing to our use of cookies. (More details)
Portal > Offres > Offre UMR7280-CHLFER-005 - CDD chercheur (H/F)

Post-doc in innate immunity in C. elegans

This offer is available in the following languages:
Français - Anglais

Ensure that your candidate profile is correct before applying. Your profile information will be added to the details for each application. In order to increase your visibility on our Careers Portal and allow employers to see your candidate profile, you can upload your CV to our CV library in one click!

Faites connaître cette offre !

General information

Reference : UMR7280-CHLFER-005
Workplace : MARSEILLE 09
Date of publication : Monday, August 05, 2019
Type of Contract : FTC Scientist
Contract Period : 24 months
Expected date of employment : 1 October 2019
Proportion of work : Full time
Remuneration : From 2606 €uros gross monthly salary
Desired level of education : PhD
Experience required : Indifferent


Take part in an on-going project aiming to dissect cross-tissue signaling in C. elegans innate immunity.


- Select and adapt analytical and experimental methods according to research objectives within a specialized approach (imaging, biochemistry, transgenesis)
- Develop techniques adapted to a methodological approach to biology
- Write experimental reports, scientific articles
- Design and optimize experiments within a field of biology study: genetics, cell biology, innate immunity, transgenesis
- Participate in the management of the technical, human and financial resources allocated
- Ensure the application of health and safety principles and rules


PhD with in-depth knowledge of either C. elegans or molecular genetic approaches.
Specific equipment (in-depth knowledge)
Biology: methodology applied (general knowledge)
Health and safety regulations
English language: B1 to B2 (Common European Framework of Reference for Languages)

Work Context

Work within Jonathan Ewbank's research team at the Marseille-Luminy Immunology Center (see

We talk about it on Twitter!